It covers the HPV+ Recurrent/Metastatic Head and NeckCancerPipeline drug profiles, including clinical and nonclinical stage products ...Curious about the latest updates in the HPV+ Recurrent/Metastatic Head and Neck Cancer Pipeline? @.
... today announced a global initiative to enhance consumer awareness of HPV diseases and HPV-related cervical cancer prevention across emerging markets, beginning with India, Indonesia, and Thailand.
Certain high-risk HPV types can cause changes in cervical cells that may eventually develop into cancer if left untreated. Regular screening helps identify these infections and abnormal cell changes... .
Researchers said the finding gives India its first validated indigenous point-of-care HPV screening test.HPV infection is the necessary cause of cervical cancer, one of the most common cancers among Indian women.
The state govt on Monday said the Human Papillomavirus (HPV) vaccination drive has been extended by three months till August, following Centre’s directions to ensure full coverage before schools ...